{{Rsnum
|rsid=35683
|Gene=GHRL
|Chromosome=3
|position=10286566
|Orientation=plus
|GMAF=0.2994
|Gene_s=GHRL,GHRLOS
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;C)
|geno3=(C;C)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;C)
| geno3=(C;C)
| CEU | 23.0 | 45.1 | 31.9
| HCB | 0.0 | 5.8 | 94.2
| JPT | 0.0 | 2.7 | 97.3
| YRI | 12.9 | 42.9 | 44.2
| ASW | 14.0 | 42.1 | 43.9
| CHB | 0.0 | 5.8 | 94.2
| CHD | 0.0 | 1.8 | 98.2
| GIH | 2.0 | 26.7 | 71.3
| LWK | 16.4 | 45.5 | 38.2
| MEX | 19.0 | 39.7 | 41.4
| MKK | 36.5 | 44.2 | 19.2
| TSI | 23.5 | 44.1 | 32.4
| HapMapRevision=28
}}{{PMID Auto
|PMID=20920174
|Title=Polymorphisms of genes coding for ghrelin and its receptor in relation to colorectal cancer risk: a two-step gene-wide case-control study
|OA=1
}}

{{PMID Auto
|PMID=17389697
|Title=Examining the candidacy of ghrelin as a gene responsible for variation in adult stature in a United Kingdom population with type 2 diabetes.
}}

{{PMID Auto
|PMID=19077438
|Title=Analysis of 30 genes (355 SNPS) related to energy homeostasis for association with adiposity in European-American and Yup'ik Eskimo populations.
|OA=1
}}

{{PMID Auto
|PMID=21390334
|Title=Genetic polymorphisms in the hypothalamic pathway in relation to subsequent weight change--the DiOGenes study.
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | Illumina Human 1M}}